1. Home
  2. ALZN vs UCAR Comparison

ALZN vs UCAR Comparison

Compare ALZN & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • UCAR
  • Stock Information
  • Founded
  • ALZN 2016
  • UCAR 2013
  • Country
  • ALZN United States
  • UCAR China
  • Employees
  • ALZN N/A
  • UCAR N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • UCAR Retail-Auto Dealers and Gas Stations
  • Sector
  • ALZN Health Care
  • UCAR Consumer Discretionary
  • Exchange
  • ALZN Nasdaq
  • UCAR Nasdaq
  • Market Cap
  • ALZN 7.5M
  • UCAR 8.8M
  • IPO Year
  • ALZN 2021
  • UCAR 2023
  • Fundamental
  • Price
  • ALZN $2.32
  • UCAR $2.04
  • Analyst Decision
  • ALZN Strong Buy
  • UCAR
  • Analyst Count
  • ALZN 1
  • UCAR 0
  • Target Price
  • ALZN $45.00
  • UCAR N/A
  • AVG Volume (30 Days)
  • ALZN 71.9K
  • UCAR 31.1K
  • Earning Date
  • ALZN 09-10-2025
  • UCAR 10-07-2025
  • Dividend Yield
  • ALZN N/A
  • UCAR N/A
  • EPS Growth
  • ALZN N/A
  • UCAR N/A
  • EPS
  • ALZN N/A
  • UCAR N/A
  • Revenue
  • ALZN N/A
  • UCAR $6,067,871.00
  • Revenue This Year
  • ALZN N/A
  • UCAR N/A
  • Revenue Next Year
  • ALZN N/A
  • UCAR N/A
  • P/E Ratio
  • ALZN N/A
  • UCAR N/A
  • Revenue Growth
  • ALZN N/A
  • UCAR 124.09
  • 52 Week Low
  • ALZN $2.06
  • UCAR $1.74
  • 52 Week High
  • ALZN $22.23
  • UCAR $9.43
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 40.27
  • UCAR 39.26
  • Support Level
  • ALZN $2.34
  • UCAR $1.91
  • Resistance Level
  • ALZN $2.53
  • UCAR $2.07
  • Average True Range (ATR)
  • ALZN 0.13
  • UCAR 0.11
  • MACD
  • ALZN 0.02
  • UCAR 0.06
  • Stochastic Oscillator
  • ALZN 29.03
  • UCAR 57.93

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: